SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
38 hedge funds and large institutions have $39.8M invested in scPharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.69% less ownership
Funds ownership: 58.03% → 57.34% (-0.69%)
56% less capital invested
Capital invested by funds: $90.1M → $39.8M (-$50.3M)
Holders
38
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$416K | |
| 2 | +$177K | |
| 3 | +$154K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$76K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$74K |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$1.3M | |
| 3 | -$415K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$383K |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$241K |